Introduction:
Ashish Kacholia is a prominent Indian investor known for his sharp stock-picking skills, particularly in the small and mid-cap segments. He co-founded Hungama Digital and later ventured into the stock market.
In Q2FY25, renowned investor Ashish Kacholia’s portfolio witnessed significant activity with new investments, showcasing his strategic approach. As per the latest filing, Ashish Kacholia holds 42 stocks with a net worth of over Rs. 2,938 crore in India, reflecting his confidence in emerging opportunities.
In Q2 FY25, the stock held by Ashish Kacholia saw an increase in stake by FIIs as follows:
Jyoti Structures:
According to the latest Q2 shareholding data, Ashish Kacholia has acquired a new position in Jyoti Structures Ltd, holding 22,036,118 shares valued at ₹70.4 Crore, representing 2.5% of the company as of September 2024.
On November 29, 2024, Jyoti Structures Ltd. opened at ₹30.31, down 0.46% from ₹30.23. The stock reached a high of ₹30.51 (0.66%) and a low of ₹29.10. By 4:00 PM, it traded at ₹29.37, a 2.84% decline, with a market cap of ₹2,576.84 crore.
Jyoti Structures Ltd specialises in engineering, procurement, and construction services for power transmission and distribution projects. The company is known for its comprehensive solutions and robust infrastructure development capabilities, catering to both domestic and international markets.
Also Read: Does Intelligence Equate to Efficiency? Artificial Intelligence and Market Volatility
Bharat Parenterals:
According to the latest Q2 shareholding data, Ashish Kacholia has recently taken a position in Bharat Parenterals Ltd., holding 129,018 shares valued at ₹19.4 Crore, which accounts for 2.0% of the company as of September 2024.
On November 29, 2024, Bharat Parenterals Ltd. opened at ₹1,768.00, up 1.56% from ₹1,740.95. The stock reached a high of ₹1,823.00 (4.67%) and a low of ₹1,720.50. By 4:00 PM, it traded at ₹1,799.15, a 3.34% increase, with a market cap of ₹1,173.85 crore.
Bharat Parenterals Ltd is a pharmaceutical company specialising in the development and manufacturing of formulations and APIs. It serves both domestic and international markets, focusing on quality and innovation to deliver effective healthcare solutions across therapeutic categories, ensuring customer satisfaction and global compliance.
Also Read: Hotel stock announces 33% YoY growth in net profits; Do you hold it?
E2E Networks:
According to the latest Q2 shareholding data, Ashish Kacholia has acquired a new position in E2E Networks Ltd, holding 177,043 shares valued at ₹78.0 Crore, representing a 1.1% stake in the company as of September 2024.
On November 29, 2024, E2E Networks Ltd opened at ₹4,500.05, down 3.67% from ₹4,671.45. The stock reached a high of ₹4,595.00 and a low of ₹4,437.90. By 4:00 PM, it traded at ₹4,437.90, a 5.00% decline, with a market cap of ₹7,493.07 crore.3
E2E Networks Ltd specialises in providing cloud infrastructure solutions, catering to businesses with scalable and cost-effective cloud services. Focused on innovation, it supports various industries, enabling efficient digital transformation. The company is recognized for its reliability, performance, and customer-centric approach in the cloud computing domain.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
